Summary & Overview
HCPCS M0064: Brief Psychiatric Medication Management Visit
HCPCS Level II code M0064 represents a brief office visit solely for monitoring or changing drug prescriptions used to treat mental, psychoneurotic, and personality disorders. Nationally, this code identifies a focused encounter centered on medication management rather than comprehensive psychiatric evaluation, which affects billing workflows, encounter documentation, and service categorization across outpatient settings.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for using M0064, typical sites of service, and which types of encounters the code is intended to capture. The publication also outlines common benchmarking topics and policy considerations that affect billing and claims adjudication, including payer coverage variations, documentation expectations, and how M0064 is positioned relative to other outpatient psychiatric visit codes.
This summary provides a national perspective useful for clinicians, billing professionals, and policy analysts seeking to understand when a focused medication-management visit should be coded as M0064, what payers generally consider in coverage decisions, and which operational and clinical factors influence appropriate use. Data not available in the input.
Billing Code Overview
HCPCS Level II code M0064 denotes a brief office visit provided solely for the purpose of monitoring or changing drug prescriptions used in the treatment of mental, psychoneurotic, and personality disorders.
Service type: Medication management visit for psychiatric conditions.
Typical site of service: Outpatient office or clinic setting where a prescriber or qualified clinician evaluates medication effectiveness and adjusts prescriptions as needed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 34-year-old adult with a diagnosis of moderate major depressive disorder stabilized on a selective serotonin reuptake inhibitor (SSRI). The patient presents for a brief office visit solely to monitor medication response and adjust dose due to emerging insomnia and mild anxiety. The visit is limited to prescription management: review of current medications, assessment of side effects and adherence, brief symptom check (sleep, mood, anxiety), documentation of decision to increase the SSRI dose by 25 mg, and arrangement for a follow-up telehealth or in-person medication check in two weeks. No psychotherapy, extended counseling, or comprehensive physical exam is performed during this visit. Typical workflow: patient schedules medication monitoring visit; nurse or medical assistant updates medication list and vitals as required by clinic policy; clinician conducts a focused, time-limited medication review and documents rationale for change and informed consent for dose adjustment; prescription is sent to pharmacy; visit is coded using M0064 and any applicable modifiers are appended when required by payer rules.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable evaluation and management service by the same physician on the same day of a procedure | Use when a full E/M beyond medication management is provided the same day as another procedure |